Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort-Reference-Cited by-同舟云学术

Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort

Published:2017 Issue:14 Volume:23 Page:2545
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:en
Short-container-title:WJG

Author:

Adhoute Xavier,Pénaranda Guillaume,Raoul Jean Luc,Edeline Julien,Blanc Jean-Frédéric,Pol Bernard,Campanile Manuela,Perrier Hervé,Bayle Olivier,Monnet Olivier,Beaurain Patrick,Muller Cyril,Castellani Paul,Le Treut Yves Patrice,Bronowicki Jean Pierre,Bourlière Marc

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference61 articles.

1. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodés J. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001;35:421-430.

2. Management of hepatocellular carcinoma

3. EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

4. Asian Consensus Workshop Report: Expert Consensus Guideline for the Management of Intermediate and Advanced Hepatocellular Carcinoma in Asia

5. Heterogeneity of Patients with Intermediate (BCLC B) Hepatocellular Carcinoma: Proposal for a Subclassification to Facilitate Treatment Decisions

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical features and prognostic factors in patients with microvascular infiltration of hepatocellular carcinoma: Development and validation of a nomogram and risk stratification based on the SEER database;Frontiers in Oncology;2022-09-14

2. Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysis;Journal of Gastrointestinal Cancer;2022-05-30

3. Potential of PALBI‐T score as a prognostic model for hepatocellular carcinoma in alcoholic liver disease;JGH Open;2022-01

4. Differentiation of clinical patterns and survival outcomes of hepatocellular carcinoma on hepatitis B and nonalcoholic fatty liver disease;Journal of the Chinese Medical Association;2021-06

5. A Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatocellular Carcinoma: Single-Center Analyses With Internal Validation;Frontiers in Oncology;2021-03-04